METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
André N, Deley MCL, Léguillette C, Probst A, Willems L, Travers R, Aerts I, Faure-Conter C, Revond-Riviere G, Min V, Geoerger B, Chastagner P, Entz-Werlé N, Leblond P.
André N, et al. Among authors: travers r.
Eur J Cancer. 2024 Feb;198:113525. doi: 10.1016/j.ejca.2024.113525. Epub 2024 Jan 6.
Eur J Cancer. 2024.
PMID: 38199147
Free article.
Clinical Trial.